Jack Phillips - Nov 13, 2023 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role
Chief Executive Officer, Director
Signature
/s/ David Patience, attorney-in-fact
Stock symbol
AXDX
Transactions as of
Nov 13, 2023
Transactions value $
-$4,157
Form type
4
Date filed
11/14/2023, 05:05 PM
Previous filing
Oct 16, 2023
Next filing
Dec 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXDX Common Stock Options Exercise $0 +1.72K +2.99% $0.00 59.3K Nov 13, 2023 Direct F1
transaction AXDX Common Stock Sale -$4.16K -745 -1.26% $5.58 58.6K Nov 13, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXDX Employee Restricted Stock Units Options Exercise $0 -1.72K -50.01% $0.00 1.72K Nov 13, 2023 Common Stock 1.72K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On May 20, 2021, the reporting person was granted a total of 20,659 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023.
F2 The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.